Patient Alerting Logistics Launches Medical Device Tracking and Critical Healthcare Messaging Service

Patient Alerting Logistics today announced the commercial launch of its revolutionary digital communications platform connecting the complete healthcare ecosystem for crucial near real-time messaging for medical devices and other critical healthcare issues.

Patient Alerting Logistics reports this first-ever computerized, managed service offering connects device manufacturers, distributors, hospitals, physicians, regulators, researchers, and patients to help promote safety and regulatory compliance. Simultaneous with the launch, PAL also named two industry veterans to lead its sales success.

PAL – Facilitating Communications Across the Complete Healthcare Ecosystem

A sophisticated, computerized communications hub, the PAL platform aggregates and shares relevant device information from traditionally fragmented sources and works continuously to ensure communication links are current, fast, and secure.  The platform can track an implanted device throughout its entire useful life, from initial manufacture to explant.  It seamlessly integrates with an EMR to automatically associate a patient with a specific device. The PAL platform replaces existing data silos as well as many traditionally disjointed manual processes, including communication through the postal system, with an advanced, automated system to ensure: Message sent. Message delivered. Every time.

Benefitting device manufacturers in particular, PAL seamlessly captures FDA-mandated device tracking information from healthcare providers and other final device distributors.  Using PAL, a manufacturer can issue a device recall in minutes, if needed.  Notifications are delivered immediately to potentially impacted patients, hospitals, and other relevant healthcare constituents, potentially sparing patient harm, lives, and legal actions. Additionally, the platform tracks information the FDA may require from vendors for post-market device surveillance. It also streamlines healthcare provider compliance with required patient information updates, supporting faster and more accurate device information flow throughout the healthcare system.

“PAL answers a significant, long-overdue need,” comments Paul Dandrow, PAL Chairman and CEO.  “Device tracking, in particular, and communications across the global healthcare ecosystem are mired in antiquated processes, diminishing quality of care and negatively impacting every stakeholder.  Even prior to our service’s launch, we have already received significant interest in our innovative service offering from across the industry.  The addition of these two strong industry sales leaders will allow us to convert that interest into continued success and rapid growth.”

Timothy Chunn, Vice President of Sales for Medical Device Manufacturers

Timothy Chunn, a 25-year healthcare technology veteran with broad IT experience, joins PAL as Vice President of Sales for Medical Device Manufacturers.  He will be responsible for formulating sales strategies, promoting PAL’s service offerings, and building long-term relationships in the device manufacturing marketplace. Most recently, as a business development director for NetApp IT, Mr. Chunn expanded the company’s global business with direct sales teams and developed new channel partners, software introductions, and analytics alliances. During his career he has also held executive leadership positions at BridgeHead Software, Dell Healthcare & Life Sciences, Symantec, and Bycast.

Perrish Dailey, Vice President of Sales for Healthcare Providers

Perrish Dailey joins PAL as Vice President of Sales for Healthcare Providers, bringing 25 years of successful sales leadership experience to the company.  Mr. Dailey will be responsible for developing and implementing field sales strategies and tactics and managing ongoing customer relationships. He excels at helping to develop and deliver new technology solutions and supporting them through outstanding sales leadership and customer service that drive exponential revenue growth. Most recently, Mr. Dailey was President and Chief Operations Officer at Rivera Group where he was responsible for complete corporate operations for the innovative cybersecurity firm.  During his career, he also held successive leadership positions focused on healthcare at Dell, culminating in Global Director for Dell Services.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”